Smoore's Subsidiary CCELL Faces Antitrust Lawsuit in the U.S., Accused of Price Manipulation and Market Monopoly

Jul.03
Smoore's Subsidiary CCELL Faces Antitrust Lawsuit in the U.S., Accused of Price Manipulation and Market Monopoly
A U.S. federal court in Arizona has recently accepted a class-action lawsuit against Chinese e-cigarette manufacturer Smoore and its U.S. distributor. The suit accuses them of monopolizing the U.S. cannabis vape market through price manipulation and market division, resulting in higher costs for consumers. This marks the second such case filed this year.

Key Points:

 

·Monopoly Accusation: Smoore is accused of manufacturing 80% of the closed-system marijuana oil e-cigarette devices in the United States and forcing distributors to adhere to minimum pricing and prohibiting the sale of competing products. 

 

·Anticompetitive Behavior: The lawsuit alleges that Smoore conspired with distributors for ten years, sharing pricing data, dividing the market, and collecting $500,000 in security deposits to prevent violations. 

 

·Legal Basis: The plaintiffs are seeking compensation under the Sherman Antitrust Act, the Clayton Antitrust Act, and laws of 31 states for the high prices consumers have faced due to monopolistic practices. 

 

·Case Status: Smoore has not yet responded, and the case is filed under docket number 2:25-cv-02259 in the Federal Court of Arizona. 

 


【2Firsts news flash】According to a report by Law 360 on July 2nd, the Chinese marijuana e-cigarette brand CCELL and its several American distributors are accused of engaging in anticompetitive price manipulation to gain market dominance. This class-action lawsuit is the second this year to make similar allegations.

 

According to a lawsuit filed on June 28 in a federal court in Arizona, Shenzhen Smoore Technology Co. Ltd. and Smoore International Holdings Ltd. devised a plan to allocate market dominance by requiring distributors to agree to minimum prices and prohibiting them from selling competing products.

 

The complaint alleges that "Smoore is the monopolist in the American market for the production of closed-loop cannabis oil e-cigarette devices, manufacturing up to 80% of the products in the United States and selling them directly to cannabis producers and wholesale distributors, including the defendant distributor.

 

According to the lawsuit, Smoore is both a supplier to the distributor defendants mentioned in the lawsuit, as well as a competitor, including the largest CCELL product distributor in the United States, Jupiter Research LLC. Despite these distributors helping Smoore establish a monopoly, the lawsuit indicates that they were forced to do so in order to continue accessing these popular products.

 

"Smoore's dominant market share has put distributors accused in a position where they must choose between either participating in Smoore's anti-competitive plan or facing the consequences of being unable to do business with Smoore. This would entail the risk of losing a crucial supply source, which holds as much as 80% of the market share in the closed-loop cannabis oil vaporization system market in the United States."

 

This class action lawsuit seeks damages under the Sherman Antitrust Act and the Clayton Antitrust Act, as well as under the antitrust laws and consumer protection laws of 31 states and regions in the United States.

 

The claims in this lawsuit are similar to a lawsuit filed in a federal court in California, but the earlier lawsuit was filed by a marijuana retailer based in Arizona, which sought compensation as a business harmed by monopolistic practices. The current lawsuit is partly based on the theory that consumers who had to pay higher prices due to these monopolistic practices are seeking compensation.

 

The complaint states that this pattern of horizontal price fixing, market division, and exclusive dealing began nearly a decade ago.

 

According to the complaint, the retailers allege that Smoore and its distributors conspired not to compete for each other's customers, as well as not to charge customers fees lower than the agreed upon price for CCELL products. The accused distributors include Jupiter, CB Solutions LLC (better known as Canna Brand Solutions), and Greenlane Holdings Inc., all of which are named defendants in the California lawsuit.

 

The lawsuit alleges that Smoore demanded distributors to share confidential pricing data and customer information with each other on a monthly basis. All distributors were required to avoid competing with each other. Each distributor was also required to pay a $500,000 deposit. If Smoore found that someone violated the terms of the illegal agreement, they would deduct funds from the violator's deposit.

 

On June 25th, representatives of the company in question did not immediately respond to requests for comment. The lawyer information for the company in question has not yet been disclosed.

 

This class action lawsuit is being represented by Cristina Perez Hesano of Perez Law Group PLLC.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Global ScholarshipProgramme Seeks Tobacco Harm Reduction Leaders of Tomorrow – One Week Left to Apply
Global ScholarshipProgramme Seeks Tobacco Harm Reduction Leaders of Tomorrow – One Week Left to Apply
Organized by UK-based K•A•C, the global Tobacco Harm Reduction Scholarship Programme enters its final week for applications. Open to all backgrounds, it offers tailored mentorship and up to $12,000 in funding to support individually designed THR projects.
Jul.24
The Consumers Association of Penang of Malaysia: Should Follow Singapore's Lead in Treating E-Cigarettes as Drugs for Comprehensive Regulation
The Consumers Association of Penang of Malaysia: Should Follow Singapore's Lead in Treating E-Cigarettes as Drugs for Comprehensive Regulation
Consumer Association of Penang (CAP) urges Malaysian government to follow Singapore in treating e-cigarettes as a drug threat.
Aug.25 by 2FIRSTS.ai
2Firsts Interviews ASDF on Malaysia’s Vape Ad Ban, Total Prohibition Plans, and What’s Next
2Firsts Interviews ASDF on Malaysia’s Vape Ad Ban, Total Prohibition Plans, and What’s Next
Malaysia’s Vape Market in Turmoil.Since the implementation of Act 852, Malaysia’s e-cigarette sector has been undergoing intense upheaval. From stricter compliance inspections and a full advertising ban to a proposal for a complete sales prohibition, a regulatory storm is reshaping the industry landscape.2Firsts talks with leading local brand ASDF to learn how it is responding to challenges and laying out a compliance roadmap in the current policy environment.
Aug.14
Talysis Report: Scotland’s E-Cigarette Sales Down 33% Year-on-Year, 2ml Pod Market Share Rises to 38.4%
Talysis Report: Scotland’s E-Cigarette Sales Down 33% Year-on-Year, 2ml Pod Market Share Rises to 38.4%
Talysis reports that after Scotland's disposable e-cigarette ban on June 1, 2025, e-cigarette sales share dropped more than the UK average. 2ml pod sets became dominant, leading to a shift in the brand landscape. Some established brands saw sales decline while new ones emerged. Illegal disposable e-cigarettes are still being sold, and nicotine pouch sales have increased.
Aug.05 by 2FIRSTS.ai
Vuse Ultra Enters Travel Retail for the First Time, Starting from Frankfurt Airport and Expanding to the UK
Vuse Ultra Enters Travel Retail for the First Time, Starting from Frankfurt Airport and Expanding to the UK
British American Tobacco’s Vuse Ultra has entered the global travel retail channel for the first time, being sold at Frankfurt Airport from August to September and planning to expand to certain airports in the UK.
Aug.13 by 2FIRSTS.ai
Australian authorities seize $30,000 worth of illegal e-cigarettes in Melbourne crackdown
Australian authorities seize $30,000 worth of illegal e-cigarettes in Melbourne crackdown
The Therapeutic Goods Administration (TGA), in cooperation with Victoria Police, seized illegal e-cigarettes worth approximately AUD 40,000 (about USD 30,000), along with illegal tobacco and cash, from a retail store in a prime location of Melbourne’s central business district. The store is suspected of violating relevant laws. Australia imposes strict penalties for illegal e-cigarettes, and since July 1, 2024, e-cigarettes may only be sold through pharmacies, with all advertising considered ill
Aug.14 by 2FIRSTS.ai